GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,000 | -68.1% | 10,210 | -41.3% | 0.00% | – |
| Q2 2019 | $72,000 | -93.0% | 17,384 | -91.3% | 0.00% | -100.0% |
| Q1 2019 | $1,026,000 | +1052.8% | 200,724 | +231.1% | 0.00% | – |
| Q2 2016 | $89,000 | +1.1% | 60,617 | -1.6% | 0.00% | – |
| Q1 2016 | $88,000 | -14.6% | 61,596 | -2.2% | 0.00% | – |
| Q4 2015 | $103,000 | -27.0% | 62,985 | +3.9% | 0.00% | – |
| Q3 2015 | $141,000 | -39.7% | 60,612 | -29.2% | 0.00% | – |
| Q2 2015 | $234,000 | +3.5% | 85,606 | +27.7% | 0.00% | – |
| Q1 2015 | $226,000 | -28.5% | 67,037 | -26.5% | 0.00% | – |
| Q4 2014 | $316,000 | -14.1% | 91,215 | +24.6% | 0.00% | – |
| Q3 2014 | $368,000 | -42.1% | 73,196 | +58.8% | 0.00% | -100.0% |
| Q2 2014 | $636,000 | -35.7% | 46,082 | -28.7% | 0.00% | 0.0% |
| Q1 2014 | $989,000 | +851.0% | 64,631 | +402.8% | 0.00% | – |
| Q4 2013 | $104,000 | – | 12,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 221,700 | $1,051,000 | 0.83% |
| EAM Global Investors LLC | 227,063 | $1,076,000 | 0.56% |
| EAM Investors, LLC | 319,187 | $1,513,000 | 0.25% |
| COURAGE CAPITAL MANAGEMENT LLC | 30,000 | $142,000 | 0.11% |
| Cutter & CO Brokerage, Inc. | 53,600 | $254,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 286,800 | $1,360,000 | 0.08% |
| D.A. DAVIDSON & CO. | 731,300 | $3,466,000 | 0.07% |
| Tibra Equities Europe Ltd | 63,414 | $301,000 | 0.05% |
| Advisor Group, Inc. | 556,377 | $2,637,000 | 0.04% |
| Laurel Wealth Advisors, Inc. | 21,400 | $101,000 | 0.03% |